Vir Biotechnology (VIR) Total Assets (Quarterly): 1.112B

Vir Biotechnology, Inc. (VIR)

12.12 -1.01 (-7.69%) USD | NASDAQ | Nov 12, 16:00

10.31 -1.81 (-14.93%) After-Hours: 06:39

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2018. Start Trial.

Date	Value
September 30, 2026	1.112B
June 30, 2026	1.215B
March 31, 2026	1.026B
December 31, 2025	1.025B
September 30, 2025	1.019B
June 30, 2025	1.193B
March 31, 2025	1.308B
December 31, 2024	1.424B
September 30, 2024	1.498B
June 30, 2024	1.670B
March 31, 2024	1.794B
December 31, 2023	1.960B
September 30, 2023	2.045B
June 30, 2023	2.244B
March 31, 2023	2.666B
December 31, 2022	3.052B

Date	Value
September 30, 2022	2.696B
June 30, 2022	2.619B
March 31, 2022	2.887B
December 31, 2021	2.051B
September 30, 2021	1.210B
June 30, 2021	1.058B
March 31, 2021	1.136B
December 31, 2020	918.76M
September 30, 2020	943.26M
June 30, 2020	672.24M
March 31, 2020	477.11M
December 31, 2019	512.07M
September 30, 2019	422.64M
June 30, 2019
March 31, 2019
December 31, 2018	191.60M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks